Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation

Key Points

• Ceramides are linked to renal dysfunction in patients with coronary artery disease, indicating a novel biomarker.
• Recent evidence found higher ceramide levels correlated with significant renal impairment, with specific reference ranges.
• Analysis of clinical data suggests ceramides could serve as effective biomarkers for monitoring renal health.
• This highlights the need for further research to validate ceramides' role in understanding coronary artery disease alongside renal function.